Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Healthcare Triangle Secures New Material Contract in Cloud Healthcare Push (NASDAQ: HCTI)

• Healthcare Triangle Inc. (NASDAQ: HCTI) has entered into a new material agreement to provide cloud-based healthcare solutions.

Nitish Kishor | 29 June 2026

Inhibikase Therapeutics (NASDAQ: IKT) Shareholders Approve 3M-Share Equity Plan Expansion

• Inhibikase Therapeutics (NASDAQ: IKT) shareholders approved an amendment to increase its 2020 Equity Incentive Plan by 3,000,000 shares.

Nitish Kishor | 29 June 2026

ImageneBio (NASDAQ: IMA) Finance Chief Resigns After Four-Year Tenure

• ImageneBio (NASDAQ: IMA) disclosed the resignation of Senior Vice President of Finance and Operations Robert Lally, effective July 22, 2026.

Nitish Kishor | 29 June 2026

Akari Therapeutics (NASDAQ: AKTX) Completes Final Tranche of Private Placement

• The purchase agreement covered an aggregate of 1,470,588 securities, including ADSs or prefunded warrants, each tied to 80,000 ordinary shares.

Nitish Kishor | 29 June 2026

Atara Biotherapeutics (NASDAQ: ATRA) Names Interim Financial Chief as Part of Executive Shift

• The board appointed Kevin G. Sarney as interim chief financial officer under a consulting agreement with Charles River CFO, Inc.

Nitish Kishor | 29 June 2026

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) Restructures Operations

• The company is closing its research facility in Alabama.

Nitish Kishor | 29 June 2026

Capricor Therapeutics (NASDAQ: CAPR) FDA Advisory Panel Set for July 29 Ahead of August Decision

• Capricor Therapeutics announced an FDA advisory committee meeting on July 29, 2026, to review its Biologics License Application for Deramiocel.

Nitish Kishor | 29 June 2026

Emergent BioSolutions (NYSE: EBS) Wins US Contract

• The contract is valued at $52.7 million

Nitish Kishor | 29 June 2026

Pfizer Inc. (NYSE:PFE) Gains 2.62% as PFE's Post-Pandemic Rebuild Still Has Investors Divided

• Pfizer (PFE) closed at $24.29, up 2.62% on June 26, 2026, drawing attention among large-cap healthcare stocks.

Nitish Kishor | 29 June 2026

Thermo Fisher Scientific Inc. (NYSE:TMO) Gains 1.44% as TMO’s Life-Sciences Rebound Story Gains Traction

• Thermo Fisher Scientific (TMO) closed at $513.03, up 1.44% on June 26, 2026, drawing attention among large-cap healthcare stocks.

Nitish Kishor | 29 June 2026
Support

Hi! How can we help you today?

Loading…